Upgrades Hold Buy X

NUVB Nuvation Bio

Jefferies

$1.40 $10

Upgrades Neutral Buy X

NUVB Nuvation Bio

BTIG Research

$5

Downgrades Buy Hold X

NUVB Nuvation Bio

Jefferies

$5 $2

Downgrades Outperform Mkt Perform X

NUVB Nuvation Bio

BMO Capital Markets

$8 $2.50

Downgrades Buy Neutral X

NUVB Nuvation Bio

BTIG Research

Initiated Buy X

NUVB Nuvation Bio

H.C. Wainwright

$14

Resumed Buy X

NUVB Nuvation Bio

BTIG Research

$16

Initiated Outperform X

NUVB Nuvation Bio

RBC Capital Mkts

$15

Initiated Outperform X

NUVB Nuvation Bio

BMO Capital Markets

$16

Initiated Buy X

NUVB Nuvation Bio

BTIG Research

$16

Initiated Outperform X

NUVB Nuvation Bio

Cowen

Initiated Buy X

NUVB Nuvation Bio

Jefferies

$20

Initiated Outperform X

NUVB Nuvation Bio

Wedbush

$20

NUVB  Nuvation Bio Inc

Nuvation Bio Inc., a biopharmaceutical company, focuses on the development of therapies for oncology. Its portfolio includes various oncology programs with multiple drug development candidates. Nuvation Bio Inc.was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. The company was founded in 2018 and is based in New York, New York with an additional office in San Francisco, California.